Holding pharmacy benefit managers accountable

State legislative sessions across the country are in full swing, and many state officials have made lowering the cost of medicine for patients a top priority. If policymakers are serious about...
Read More
Stopping pharmacy benefit managers from “gaming the system”

People around the country say they are paying too much for their prescription medicines. State policymakers could help address this problem now. Doing so starts with stopping pharmacy benefit...
Read More
ICYMI: PhRMA kicks off the year at the 2023 J.P. Morgan Health Care Conference

This January, PhRMA joined health care leaders, investors, R&D experts and members of the media at the 2023 J.P. Morgan Health Care Conference in San Francisco, CA. During this week, we discussed...
Read More
ICYMI: PhRMA COO Lori Reilly speaks about the health care agenda for the next Congress

With a divided Congress, bipartisan action will be necessary to move the needle on health care policy. On December 7, 2022, PhRMA sponsored the Axios event, “The Post-Midterm Health Care Agenda,”...
Read More
A key fact the White House is reluctant to admit

Today, President Biden delivered remarks that touch on recent drug pricing reforms included in the Inflation Reduction Act. While the law is deeply flawed and government price-setting is the wrong...
Read More
New survey: Voters seriously concerned about fine print in reconciliation bill

With a final vote in Congress expected on a reconciliation spending bill, a new Morning Consult survey explores what this legislation actually does – and does not do – and finds that voters are...
Read More
Myth vs. Fact: The Senate’s latest price setting proposal

The narratives being built around the Senate’s latest price setting proposal frame it as a bill intended to lower drug prices for patients and address rising inflation. But those narratives aren’t...
Read More
The Senate’s latest price setting proposal will undermine U.S. economic growth

Last week, we examined ways the latest drug pricing proposal will undermine patient access to medicines, American medical innovation and our health care system as a whole. But there is another...
Read More
Celebrating Medicare’s 57th anniversary

In case you missed it, Saturday, July 30, marked the anniversary of Medicare. For 57 years, Medicare has helped pay for medical care for Americans over the age of 65, as well as younger Americans...
Read More
New analysis finds deeper impact of drug pricing bill on biopharmaceutical researchers

A new analysis by the health care analytics and research firm Avalere reveals the partisan drug pricing bill will have a much deeper impact on the biopharmaceutical research industry than previously...
Read More